ThereseS

Professor, Center of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology

[NTNU Klinisk og Molekylær Medisin @NTNUikom]

Activation of TLRs in an inflamed or infectious bone marrow microenvironment may lead to pro-tumorigenic IL-32 expression in multiple myeloma https://t.co/KTt3k9UMMS @ThereseStandal @RosethAass @MjelleLab @KristineMisund @Hamartinka @TonjeNedal

[Trude Helen Flo @trudeflo]

3 PhD positions in Molecular Inflammation (innate immunity, cell biology, iPSCs, complement). Join us at CEMIR @NTNUikom in Trondheim, Norway for great science amongst snowcapped mountains, fjords and midnight sun (soon)☀️ Please share
https://t.co/iwFpe0SyEz

[Trude Helen Flo @trudeflo]

Only 2 weeks left to apply for the postdoc position: 4 yrs of fun with microscopy, cell biology, innate immunity. Please RT. https://t.co/N1TyCU0HZX

[NTNU Klinisk og Molekylær Medisin @NTNUikom]

Kan immunsystemet vårt kurere kreft? Kom på foredrag med Therese Standal, professor ved @NTNUikom, for å få svaret https://t.co/AJF9381dqu @ThereseStandal Rådhussalen, Trondheim folkebibliotek, onsdag 16.11.22, kl. 19

[ThereseS @ThereseStandal]

@tobiasslordahl @NTNU @StOlavshospital Grattis, Tobias!!

[ThereseS @ThereseStandal]

@KristineMisund @NTNUikom @LeukemiaJnl Gratulerer, Kristine! Imponerende!

[Martin Picard @MitoPsychoBio]

Question for mitochondriacs: Can we come up with a list of all mitochondrial functions? Beyond OxPhos and ATP synthesis, what are core mitochondrial *functions*?

Please add a reference for functions you mention below.

[Myelomatose @myelomatosenytt]

I oktober 2021 åpnet Myelomatoseregisteret i Midt-Norge. Dette er et kvalitetsregister som har som formål å bidra til bedre kvalitet på helsehjelpen til personer med myelomatose. Har du myelomatose, bor i Midt-Norge og har ikke blitt forspurt? Spør din lege!

[ThereseS @ThereseStandal]

Why is IL-32 expression in cancer cells bad for multiple myeloma patients? Kristin's PhD work is finally out! @RosethAass @tobiasslordahl @HealthNTNU Read the full story @iScience_CP
https://t.co/YOcYcl9jk8

[ThereseS @ThereseStandal]

@MennoOudhoff Congratulations, impressive work!

[ThereseS @ThereseStandal]

@barbara_loon @UniOslo @NTNUikom @NTNU Congratulations- well deserved!

[ThereseS @ThereseStandal]

Så enig!!!Godt skrevet av @IngridEftedal
Ingrid Eftedal Skjult midlertidighet i akademia er et samfunnsproblem - https://t.co/oxk0b3DJku https://t.co/ws8S3RO1xd

[ThereseS @ThereseStandal]

@MennoOudhoff @RCN_Norway @NTNUikom Congratulations Mara! 🤗

[ThereseS @ThereseStandal]

Impressive work from Kaisa Lehti and team! Congratulations!

[Lehti Lab @LehtiLab]

Happy to share our latest paper on #OvarianCancer #chemoresistance, #ECM and #biomechanics now online at @NatureComms
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
https://t.co/3odpX7BrOd

[ThereseS @ThereseStandal]

@trudeflo @NTNUikom Vel fortjent- gratulerer! 🤗

[ThereseS @ThereseStandal]

Strålende uke for forskning ved @NTNUikom! Gratulerer så mye til @trudeflo for SFF finaleplass https://t.co/HX3XBzzgzV og @barbara_loon med Anders Jahres forskningspris https://t.co/MIFd2vKjjs

[NTNU Klinisk og Molekylær Medisin @NTNUikom]

Join the NTNU Symposium on Clinical Biomarkers of Cancer - June 15-17, 2021 https://t.co/3V0wDsRQph @NTNUikom @NTNUhelse @HealthNTNU @NTNU

[Toril Holien @TorilHol]

We are hosting the 3rd International NTNU Symposium on Clinical Biomarkers of Cancer 15th-17th of June. This year online and free of charge! Registration open. Great line-up of speakers. @NTNUikom @theHUNTstudy @OsloCancer https://t.co/ojMylfEhHE

[Lehti Lab @LehtiLab]

We have open positions for #PhD, #postdoc, and lab engineer/manager @NTNU Trondheim, Norway.
Interested in #tumor #microenvironment & #cancer #signaling and #ovariancancer therapy & biomarkers?
Apply now👇
https://t.co/EwTHbcv0Cv

[ThereseS @ThereseStandal]

@MennoOudhoff @jennyostrop Impressive work from you guys lately, Menno! Congrats!